Illumina Innovation Fund II GP, L.L.C.
SEC CIK 1779219 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALMR | Alamar Biosciences, Inc. | 10% | 271.8K | $4.00M | — | 3 | 2026-04-20 | 2026-04-20 |
Most active insiders at ALMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Illumina Innovation Fund II GP, L.L.C. | 10% | $4.00M | — |
| 2 | Naclerio Nicholas | Dir | $4.00M | — |
| 3 | Chen Shiping | COO, Dir | — | — |
| 4 | Luo Yuling | CEO, Dir | — | — |
| 5 | White Timothy Ogden | Pres | — | — |
| 6 | Qiming Corporate GP VI, Ltd. | 10% | — | — |
| 7 | Brottem John L. | GC | — | — |
| 8 | McAnear Justin J. | CFO | — | — |
| 9 | RAGUSA ROBERT P | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-04-20 20:45 | 2026-04-20 | ALMR | Alamar Biosciences, Inc. | Illumina Innovation Fund II GP, L.L.C. | 10% | C - Cnv Deriv | — | +6.13M | 271.8K | New | — |
| DMI | 2026-04-20 20:45 | 2026-04-20 | ALMR | Alamar Biosciences, Inc. | Illumina Innovation Fund II GP, L.L.C. | 10% | J - Other | — | 0 | 5.51M | New | — |
| DI | 2026-04-20 20:45 | 2026-04-20 | ALMR | Alamar Biosciences, Inc. | Illumina Innovation Fund II GP, L.L.C. | 10% | P - Purchase | $17.00 | +235.3K | 507.1K | +87% | +$4.00M |
Purchase Sale Sale after option exercise All abbreviations